Lupus Science & Medicine®
is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.
Impact factor: 3.7
Citescore: 5.3
All metrics >>
Publish in LSM
Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.
Information is also provided on editorial policies and open access.
This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.
All manuscripts should be submitted online.
Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.
Latest Articles
Lupus nephritis:
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS9 November 2024
Lupus nephritis:
Using photovoice to investigate patient experiences of lupus nephritis in Canada7 November 2024
Reproductive health and APS:
Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis30 October 2024
Childhood lupus:
Improving routine mental health screening for depression and anxiety in a paediatric lupus clinic: a quality improvement initiative for enhanced mental healthcare22 October 2024
Epidemiology and outcomes:
Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research14 October 2024
Lupus Academy 2024
Lupus Science & Medicine was delighted to be the official journal of the 13th annual meeting of the Lupus Academy 2024. The meeting took place 6-8 September in Amsterdam, The Netherlands.
The abstracts from the conference were published as a supplement to Lupus Science & Medicine.
LSM Podcasts
Featured Video
Lupus Science & Medicine
The official journal of the Lupus Foundation of America and the premier open-access journal dedicated to lupus research.
Find out moreAltmetrics
Most Read Articles
Review:
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations22 May 2024
Clinical trials and drug discovery:
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease7 March 2024
Epidemiology and outcomes:
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures19 January 2024